Disclosure 0001193125-26-425032-1

SEC FORM 4

$107,897.82

Ultragenyx Pharmaceutical Inc. (RARE)

Sale of 7,066 shares at $15.27 per share.

Reporting Person Horn Howard · Officer Title Chief Financial Officer · Transaction Code S

Traded Oct 15, 2026 · Disclosed Oct 19, 2026

Source: SEC Form 4 · 0001193125-26-425032 · filed 2026-10-19 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Ultragenyx Pharmaceutical Inc. (RARE)." Disclosed 2026-10-19. https://desqlong.com/cards/0001193125-26-425032-1 (retrieved 2026-10-20).